| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4129254 | Annales de Pathologie | 2008 | 9 Pages |
Abstract
The identification of fusion genes provides new insights into the initial mechanisms of molecular events implicated in the tumorigenesis of prostate cancer. The presence of TEMPRSS2-ETS fusion in up to half of all human prostate cancers makes it perhaps the most common genetic rearrangement in human epithelial tumors. Some data suggest that TMPRSS2-ERG fusion prostate cancers have a more aggressive phenotype which may affect cancer progression and outcome in localized tumors treated with prostatectomy. This discovery should pave the way towards future targeted therapies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Vincent Molinié, Philippe Beuzeboc, Wafa K. Mahjoub,